Narrative review / 2010
In EPIC Norfolk, enterolignan intake was inversely linked to colorectal cancer in women, with no significant link between phytoestrogen intake and breast cancer.
This article reviews phytoestrogen consumption and cancer risk, focusing on findings from a nested case-control study in EPIC Norfolk. Phytoestrogen intake was not significantly associated with breast cancer risk. Colorectal cancer risk was inversely associated with enterolignan intake in women but not in men. Prostate cancer risk was positively associated with enterolignan intake, but this association became non-significant after adjusting for dairy intake, suggesting enterolignans may act as a surrogate marker for dairy or calcium intake.
Shows an association, not proof of cause and effect.
- Study type
- Review / nested case-control study overview
- Who was studied
- EPIC Norfolk participants (cases and controls)
- What was measured
- Risk of breast, prostate, and colorectal cancers
THE PAPER
Phytoestrogen consumption and association with breast, prostate and colorectal cancer in EPIC Norfolk.
Ward HA, Kuhnle GG. Arch Biochem Biophys, 2010.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.